Biodesix, Inc.
BDSX
$0.2867
-$0.0132-4.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -12.10% | 12.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.10% | 12.55% | |||
| Cost of Revenue | -14.72% | 3.90% | |||
| Gross Profit | -11.39% | 15.14% | |||
| SG&A Expenses | 1.13% | 1.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.17% | 0.87% | |||
| Operating Income | -38.45% | 23.80% | |||
| Income Before Tax | -34.54% | 19.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -34.54% | 19.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -34.54% | 19.57% | |||
| EBIT | -38.45% | 23.80% | |||
| EBITDA | -49.56% | 28.20% | |||
| EPS Basic | -34.64% | 19.69% | |||
| Normalized Basic EPS | -35.45% | 20.78% | |||
| EPS Diluted | -34.64% | 19.69% | |||
| Normalized Diluted EPS | -35.45% | 20.78% | |||
| Average Basic Shares Outstanding | -0.04% | 0.21% | |||
| Average Diluted Shares Outstanding | -0.04% | 0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||